Sagimet Biosciences Closes Underwritten Offering of Stock and Warrants
Sagimet Biosciences Inc. announced the closing of its underwritten offering of Series A common stock and pre-funded warrants.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sagimet Biosciences closes underwritten offering
Sagimet Biosciences said it closed an underwritten offering of Series A common stock and pre-funded warrants.